China’s gig economy

SCMP Business

–

China’s edge in fast, cost-effective early clinical trials has propelled its emergence as a global biopharmaceutical pow…

In June, Chinese regulators approved the world’s first CAR-T cell therapy for solid tumour cancers, developed by a drug …

China’s push for tech self-reliance is opening new investment opportunities in artificial intelligence stocks, but stret…

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play